Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Alvimopan

(al'' vi moe' pan)

Brand Name(s): Entereg®

IMPORTANT WARNING:

Alvimopan is only for short term use by hospitalized patients. You will receive no more than 15 doses of alvimopan during your hospital stay. You will not be given any additional alvimopan to take after you leave the hospital.

Talk to your doctor about the risks of taking alvimopan.

WHY is this medicine prescribed?

Alvimopan is used to help the bowel recover more quickly after bowel surgery, so that you can eat solid foods and have regular bowel movements. Alvimopan is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the constipation effects of opioid (narcotic) medications that are used to treat pain after surgery.

Are there OTHER USES for this medicine?

This medication should not be prescribed for other uses; ask your doctor or pharmacist for more information.

HOW should this medicine be used?

Alvimopan comes as a capsule to take by mouth. It is usually taken once shortly before bowel surgery. After the surgery, it is usually taken twice a day for up to 7 days or until hospital discharge. Your nurse will bring your medication to you when it is time for you to receive each dose.

What SPECIAL PRECAUTIONS should I follow?

Before taking alvimopan,

  • tell your doctor and pharmacist if you are allergic to alvimopan or any other medications.

  • tell your doctor if you are taking or have recently taken any opioid (narcotic) medications for pain. Your doctor may tell you not to take alvimopan if you have taken any opioid medications during the 7 days before your surgery.

  • Some medications should not be taken with alvimopan. Other medications may cause dosing changes or extra monitoring when taken with alvimopan. Make sure you have discussed any medications you are currently taking or plan to take before starting alvimopan with your doctor and pharmacist. Before starting, stopping, or changing any medications while taking alvimopan, please get the advice of your doctor or pharmacist.

  • tell your doctor if you have or have ever had a complete bowel obstruction (blockage in your intestine); or kidney or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding.

What SPECIAL DIETARY instructions should I follow?

Unless your doctor tells you otherwise, continue your normal diet.

What SIDE EFFECTS can this medicine cause?

Alvimopan may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • constipation
  • gas
  • heartburn
  • difficulty urinating
  • back pain

Alvimopan may cause other side effects. Tell your doctor if you have any unusual problems while taking this medication.

In one study, people who took alvimopan for up to 12 months were more likely to experience heart attacks than people who did not take alvimopan. However, in another study, people who took alvimopan for up to 7 days following bowel surgery were no more likely to experience heart attacks than people who did not take alvimopan. Talk to your doctor about the risks of taking alvimopan.

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

What should I do in case of OVERDOSE?

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

What OTHER INFORMATION should I know?

Ask your doctor or pharmacist if you have any questions about alvimopan.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

Houston Methodist DeBakey Cardiology Associates
6550 Fannin St.
Smith Tower, Suite 1901
Houston, TX 77030

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary